Long Non‑Coding RNAs Regulate Inflammation in Diabetic Peripheral Neuropathy by Acting as ceRNAs Targeting miR-146a-5p

References

• Forouhi NG, Wareham NJ. Epidemiology of diabetes. Medicine. 2019;47(1):22–27. doi:10.1016/j.mpmed.2018.10.004
   Google Scholar
• Iqbal Z, Azmi S, Yadav R, et al. Diabetic peripheral neuropathy: epidemiology, diagnosis, and pharmacotherapy. Clin Ther. 2018;40(6):828–849. doi:10.1016/j.clinthera.2018.04.001
   PubMed Web of Science ®Google Scholar
• Hicks CW, Selvin E. Epidemiology of peripheral neuropathy and lower extremity disease in diabetes. Curr Diab Rep. 2019;19(10):86. doi:10.1007/s11892-019-1212-8
   PubMed Web of Science ®Google Scholar
• Dewanjee S, Das S, Das AK, et al. Molecular mechanism of diabetic neuropathy and its pharmacotherapeutic targets. Eur J Pharmacol. 2018;833:472–523. doi:10.1016/j.ejphar.2018.06.034
   PubMed Web of Science ®Google Scholar
• Singh R, Kishore L, Kaur N. Diabetic peripheral neuropathy: current perspective and future directions. Pharmacol Res. 2014;80:21–35. doi:10.1016/j.phrs.2013.12.005
   PubMed Web of Science ®Google Scholar
• Callaghan BC, Cheng HT, Stables CL, Smith AL, Feldman EL. Diabetic neuropathy: clinical manifestations and current treatments. Lancet Neurol. 2012;11(6):521–534. doi:10.1016/S1474-4422(12)70065-0
   PubMed Web of Science ®Google Scholar
• Selvarajah D, Kar D, Khunti K, et al. Diabetic peripheral neuropathy: advances in diagnosis and strategies for screening and early intervention. Lancet Diabetes Endocrinol. 2019;7(12):938–948. doi:10.1016/S2213-8587(19)30081-6
   PubMed Web of Science ®Google Scholar
• Szymański M, Barciszewski J. Beyond the proteome: non-coding regulatory RNAs. Genome Biol. 2002;3(5):reviews0005.
   PubMedGoogle Scholar
• Uchida S, Adams JC. Physiological roles of non-coding RNAs. Am J Physiol Cell Physiol. 2019;317(1):C1–C2. doi:10.1152/ajpcell.00114.2019
   PubMed Web of Science ®Google Scholar
• Yamamura S, Imai-Sumida M, Tanaka Y, Dahiya R. Interaction and cross-talk between non-coding RNAs. Cell Mol Life Sci. 2018;75(3):467–484. doi:10.1007/s00018-017-2626-6
   PubMed Web of Science ®Google Scholar
• Matsui M, Corey DR. Non-coding RNAs as drug targets. Nat Rev Drug Discov. 2017;16(3):167–179. doi:10.1038/nrd.2016.117
   PubMed Web of Science ®Google Scholar
• Jandura A, Krause HM. The new RNA world: growing evidence for long noncoding RNA functionality. Trends Genet. 2017;33(10):665–676. doi:10.1016/j.tig.2017.08.002
   PubMed Web of Science ®Google Scholar
• Rupaimoole R, Slack FJ. MicroRNA therapeutics: towards a new era for the management of cancer and other diseases. Nat Rev Drug Discovery. 2017;16(3):203–222. doi:10.1038/nrd.2016.246
   PubMed Web of Science ®Google Scholar
• Salmena L, Poliseno L, Tay Y, Kats L, Pandolfi PP. A ceRNA hypothesis: the Rosetta stone of a hidden RNA language? Cell. 2011;146(3):353–358. doi:10.1016/j.cell.2011.07.014
   PubMed Web of Science ®Google Scholar
• Tay Y, Rinn J, Pandolfi PP. The multilayered complexity of ceRNA crosstalk and competition. Nature. 2014;505(7483):344–352. doi:10.1038/nature12986
   PubMed Web of Science ®Google Scholar
• Thomas AA, Biswas S, Feng B, Chen S, Gonder J, Chakrabarti S. lncRNA H19 prevents endothelial-mesenchymal transition in diabetic retinopathy. Diabetologia. 2019;62(3):517–530. doi:10.1007/s00125-018-4797-6
   PubMed Web of Science ®Google Scholar
• Yan B, Yao J, Liu J-Y, et al. lncRNA-MIAT regulates microvascular dysfunction by functioning as a competing endogenous RNA. Circ Res. 2015;116(7):1143–1156. doi:10.1161/CIRCRESAHA.116.305510
   PubMed Web of Science ®Google Scholar
• Fachrul M, Utomo DH, Parikesit AA. lncRNA-based study of epigenetic regulations in diabetic peripheral neuropathy. In Silico Pharmacol. 2018;6(1):7. doi:10.1007/s40203-018-0042-8
   PubMedGoogle Scholar
• Yu W, Zhao GQ, Cao RJ, Zhu ZH, Li K. LncRNA NONRATT021972 was associated with neuropathic pain scoring in patients with Type 2 diabetes. Behav Neurol. 2017;2017:2941297. doi:10.1155/2017/2941297
   PubMed Web of Science ®Google Scholar
• Feng Y, Chen L, Luo Q, Wu M, Chen Y, Shi X. Involvement of microRNA-146a in diabetic peripheral neuropathy through the regulation of inflammation. Drug Des Devel Ther. 2018;12:171–177. doi:10.2147/DDDT
   PubMed Web of Science ®Google Scholar
• Luo Q, Feng Y, Xie Y, et al. Nanoparticle-microRNA-146a-5p polyplexes ameliorate diabetic peripheral neuropathy by modulating inflammation and apoptosis. Nanomedicine. 2019;17:188–197. doi:10.1016/j.nano.2019.01.007
   PubMed Web of Science ®Google Scholar
• Shi X, Chen Y, Nadeem L, Xu G. Beneficial effect of TNF-α inhibition on diabetic peripheral neuropathy. J Neuroinflammation. 2013;10:69. doi:10.1186/1742-2094-10-69
   PubMed Web of Science ®Google Scholar
• Feng S-D, Yang J-H, Yao CH, et al. Potential regulatory mechanisms of lncRNA in diabetes and its complications. Biochem Cell Biol. 2017;95(3):361–367. doi:10.1139/bcb-2016-0110
   PubMedGoogle Scholar
• Liu S-X, Zheng F, Xie K-L, Xie M-R, Jiang L-J, Cai Y. Exercise reduces insulin resistance in Type 2 diabetes mellitus via mediating the lncRNA MALAT1/MicroRNA-382-3p/resistin axis. Mol Ther Nucleic Acids. 2019;18:34–44. doi:10.1016/j.omtn.2019.08.002
   PubMedGoogle Scholar
• Lin Z, Li X, Zhan X, et al. Construction of competitive endogenous RNA network reveals regulatory role of long non-coding RNAs in type 2 diabetes mellitus. J Cell Mol Med. 2017;21(12):3204–3213. doi:10.1111/jcmm.2017.21.issue-12
   PubMedGoogle Scholar
• Chen K, Ma Y, Wu S, et al. Construction and analysis of a lncRNA‑miRNA‑mRNA network based on competitive endogenous RNA reveals functional lncRNAs in diabetic cardiomyopathy. Mol Med Rep. 2019;20(2):1393–1403. doi:10.3892/mmr.2019.10361
   PubMedGoogle Scholar
• Lin X, Zhan JK, Zhong JY, et al. lncRNA-ES3/miR-34c-5p/BMF axis is involved in regulating high-glucose-induced calcification/senescence of VSMCs. Aging (Albany NY). 2019;11(2):523–535. doi:10.18632/aging.101758
   PubMedGoogle Scholar
• Wu Y, Jia K, Wu H, et al. A comprehensive competitive endogenous RNA network pinpoints key molecules in diabetic retinopathy. Mol Med Rep. 2019;19(2):851–860. doi:10.3892/mmr.2018.9715
   PubMedGoogle Scholar
• Guo G, Ren S, Kang Y, et al. Microarray analyses of lncRNAs and mRNAs expression profiling associated with diabetic peripheral neuropathy in rats. J Cell Biochem. 2019;120(9):15347–15359. doi:10.1002/jcb.v120.9
   PubMed Web of Science ®Google Scholar
• Jeggari A, Marks DS, Larsson E. miRcode: a map of putative microRNA target sites in the long non-coding transcriptome. Bioinformatics. 2012;28(15):2062–2063. doi:10.1093/bioinformatics/bts344
   PubMed Web of Science ®Google Scholar
• Li J-H, S L, Zhou H, Qu L-H, Yang J-H. starBase v2.0: decoding miRNA-ceRNA, miRNA-ncRNA and protein-RNA interaction networks from large-scale CLIP-Seq data. Nucleic Acids Res. 2014;42(D1):D92–D97. doi:10.1093/nar/gkt1248
   PubMed Web of Science ®Google Scholar
• Agarwal V, Bell GW, Nam J-W, Bartel DP. Predicting effective microRNA target sites in mammalian mRNAs. Elife. 2015;4:e05005. doi:10.7554/eLife.05005
   PubMed Web of Science ®Google Scholar
• Betel D, Koppal A, Agius P, Sander C, Leslie C. Comprehensive modeling of microRNA targets predicts functional non-conserved and non-canonical sites. Genome Biol. 2010;11(8):R90. doi:10.1186/gb-2010-11-8-r90
   PubMed Web of Science ®Google Scholar
• Chou C-H, Shrestha S, Yang C-D, et al. miRTarBase update 2018: a resource for experimentally validated microRNA-target interactions. Nucleic Acids Res. 2018;46(D1):D296–D302. doi:10.1093/nar/gkx1067
   PubMed Web of Science ®Google Scholar
• Liu W, Wang X. Prediction of functional microRNA targets by integrative modeling of microRNA binding and target expression data. Genome Biol. 2019;20(1):18. doi:10.1186/s13059-019-1629-z
   PubMed Web of Science ®Google Scholar
• He Y, Huang C, Sun X, Long X-R, Lv X-w LJ. MicroRNA-146a modulates TGF-beta1-induced hepatic stellate cell proliferation by targeting SMAD4. Cell Signal. 2012;24(10):1923–1930. doi:10.1016/j.cellsig.2012.06.003
   PubMed Web of Science ®Google Scholar
• Xie Q, Wei W, Ruan J, et al. Effects of miR-146a on the osteogenesis of adipose-derived mesenchymal stem cells and bone regeneration. Sci Rep. 2017;7:42840. doi:10.1038/srep42840
   PubMed Web of Science ®Google Scholar
• Zeng Z, Gong H, Li Y, et al. Upregulation of miR-146a contributes to the suppression of inflammatory responses in LPS-induced acute lung injury. Exp Lung Res. 2013;39(7):275–282. doi:10.3109/01902148.2013.808285
   PubMed Web of Science ®Google Scholar
• Wei J, Wang J, Zhou Y, Yan S, Li K, Lin H. MicroRNA-146a contributes to SCI recovery via regulating and expression. Biomed Res Int. 2016;2016:4013487. doi:10.1155/2016/4013487
   PubMedGoogle Scholar
• Liu XS, Fan B, Szalad A, et al. MicroRNA-146a Mimics reduce the peripheral neuropathy in Type 2 diabetic mice. Diabetes. 2017;66(12):3111–3121. doi:10.2337/db16-1182
   PubMed Web of Science ®Google Scholar
• Zhang P, Hou S, Chen J, et al. Smad4 deficiency in smooth muscle cells initiates the formation of aortic aneurysm. Circ Res. 2016;118(3):388–399. doi:10.1161/CIRCRESAHA.115.308040
   PubMed Web of Science ®Google Scholar
• Wang L, Qiao Q, Ferrao R, et al. Crystal structure of human IRAK1. Proc Natl Acad Sci USA. 2017;114(51):13507–13512. doi:10.1073/pnas.1714386114
   PubMedGoogle Scholar
• Min Y, Kim M-J, Lee S, Chun E, Lee K-Y. Inhibition of TRAF6 ubiquitin-ligase activity by PRDX1 leads to inhibition of NFKB activation and autophagy activation. Autophagy. 2018;14(8):1347–1358. doi:10.1080/15548627.2018.1474995
   PubMed Web of Science ®Google Scholar